Risk of Dementia in Older Patients with Type 2 Diabetes on Dipeptidyl-Peptidase IV Inhibitors Versus Sulfonylureas: A Real-World Population-Based Cohort Study

Background: Type 2 diabetes is related to an increased risk of dementia. Preclinical studies of dipeptidyl peptidase-IV inhibitors (DPP-4i) for dementia have yielded promising results. Therefore, we investigated the risk of dementia in elderly patients with type 2 diabetes on DPP-4is and sulfonylure...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Young-Gun, Jeon, Ja Young, Kim, Hae Jin, Kim, Dae Jung, Lee, Kwan-Woo, Moon, So Young, Han, Seung Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352270/
https://www.ncbi.nlm.nih.gov/pubmed/30597861
http://dx.doi.org/10.3390/jcm8010028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6352270/
https://www.ncbi.nlm.nih.gov/pubmed/30597861
http://dx.doi.org/10.3390/jcm8010028

Ejemplares similares